This article needs additional citations for verification .(August 2018) |
Mark S. Blumenkranz | |
---|---|
Born | October 23, 1950 |
Academic background | |
Education |
|
Academic work | |
Institutions |
Mark Scott Blumenkranz (born October 23,1950) is an American physician,surgeon,businessman,and entrepreneur. He is a trained ophthalmologist and vitreoretinal surgeon,and has served as H.J. Smead Professor and Chairman of Ophthalmology of the Byers Eye Institute at the Stanford University School of Medicine since 1997. He has founded or served on the Board of Directors of a number of companies,including Oculex,Peak Surgical,Optimedica Corporation,MacuSight,and Adverum Biotechnologies. In addition,he serves as a trustee of Brown University. [1]
Blumenkranz was born in New York City and grew up in upstate New York. He attended Brown University,where he earned a bachelor's degree,medical degree,and master's degree in biochemical pharmacology. He attended Stanford University for residency in ophthalmology,where he was chief resident,and University of Miami Bascom Palmer Eye Institute for a vitreoretinal fellowship.
Blumenkranz began his academic career as an Assistant Professor at University of Miami Bascom Palmer Eye Institute from 1980–1985. He moved to Michigan in 1985,where he became a Clinical Associate Professor at Kresge Eye Institute,Wayne State University School of Medicine. He has been a Professor at Stanford University since 1992,and has served as the Chairman of Ophthalmology at Stanford since 1997.
Blumenkranz has founded a number of successful Silicon Valley start-up companies,beginning in the 1980s. Notably,he was on the Board of Directors of Oculex Pharmaceuticals,which was later sold to Allergan. He was on the Board of Directors of MacuSight,which was later sold to Santen,Inc. He was a founder and board member of OptiMedica Corporation (later sold to Abbott Medical Optics),Peak Surgical (later sold to Medtronic),and Adverum Biotechnologies.
Blumenkranz has won the American Academy of Ophthalmology Life Achievement Award (2008),the Foundation Fighting Blindness Visionary Award (2009),AOA Brown University (2011),and the AAO Jackson Memorial Lecture (2013).
Blumenkranz is married to Recia Kott Blumenkranz,MD,and has three children,Carla,Scott,and Erik.
Ophthalmology is a branch of medicine and surgery that deals with the diagnosis and treatment of disorders of the eye. An ophthalmologist is a physician who specializes in ophthalmology. The credentials include a degree in medicine,followed by additional four to five years of residency training in ophthalmology. Residency training programs for ophthalmology may require a one-year internship with training in internal medicine,pediatrics,or general surgery. Additional specialty training may be sought in a particular aspect of eye pathology. Ophthalmologists are allowed to prescribe medications to treat eye diseases,implement laser therapy,and perform surgery when needed. Ophthalmologists may participate in academic research on the diagnosis and treatment for eye disorders.
Luis J. Haddock is a former professional tennis player from Puerto Rico. He attended Colegio Católico Notre Dame high school. He lived in his hometown of Caguas and played for the University of Notre Dame. Luis also participated on the Davis Cup team representing Puerto Rico. After graduating from the University of Puerto Rico School of Medicine,Luis was an ophthalmology resident at the Bascom Palmer Eye Institute,where he trained with Avnish A. Deobhakta,D. Wilkin Parke III and Roger A. Goldberg. In the summer of 2012,he began a vitreoretinal fellowship at the Massachusetts Eye and Ear Infirmary and Harvard Medical School in Boston,MA under his senior fellows David Kim,,Anthony Daniels and Dimitra Skondra.
Robert G. Devenyi FRCSC,FACS is a vitreoretinal surgeon and Professor of Ophthalmology and Vision Sciences at the University of Toronto. He is also the team ophthalmologist for the Toronto Maple Leafs of the National Hockey League. Devenyi is Ophthalmologist-in-Chief and Director of Retinal Services at the University Health Network (UHN),which is affiliated with the University of Toronto. Devenyi is also the co-director of the Donald K. Johnson Eye Institute located at the Toronto Western Hospital,part of UHN. The DKJ Eye Institute is Canada's premier subspeciality ophthalmology facility.
The Illinois Eye &Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice. Currently,the National Institutes of Health (NIH) ranks the department 4th nationally in ophthalmology research funding and 1st in the Midwestern United States and Chicago metropolitan area.
David Anthony Newsome M.D. FARVO was a scientist,ophthalmologist,inventor,and author. He studied the treatment of age-related macular degeneration and proposed the usefulness of zinc supplements to slow the rate of vision loss from age-related macular degeneration.
Fight for Sight is a nonprofit organization in the United States which funds medical research in vision and ophthalmology. It was formed in 1946 as the National Council to Combat Blindness (NCCB),the first non-profit in the United States to fund vision research;2011 marked its 65th anniversary.
Carmen Anthony Puliafito is an American ophthalmologist. From 2007 until March 2016,he was dean of the University of Southern California's Keck School of Medicine.
Bascom Palmer Eye Institute,of the University of Miami Leonard M. Miller School of Medicine,is a center for ophthalmic care,research,and education. Faculty and staff treat patients from around the world in facilities in Miami-Dade County,Broward County,Palm Beach County,and Collier County. The institute's full-time faculty and researchers encompass many ophthalmic sub-specialties and has been consistently ranked as the #1 eye hospital and vision research center in the country by US News &World Report.
David Paton is a retired ophthalmologist best known as founder in 1970 of Project Orbis and thereafter as its first Medical Director helping to develop (1970–1982) and then deploy its teaching aircraft for ophthalmologists worldwide,especially in the developing nations. Paton resigned from Orbis in 1987 and focused on other aspects of academic ophthalmology,but in 2011 he returned in a voluntary capacity to assist in fund raising for a new annual appointment,the David Paton Orbis Fellowship in Global Ophthalmology.
Steve Charles is a vitreoretinal surgeon who has developed many of the techniques and devices used by vitreoretinal surgeons worldwide. He is a board certified ophthalmologist and vitreoretinal surgeon,a mechanical/electrical engineer who has 48 patents or patents applied for,and has developed many of the techniques and devices used by vitreoretinal surgeons worldwide. He has performed over 38,000 vitreoretinal surgeries,lectured in 50 countries and operated in 25,delivered 17 named lectures,and over 1000 speaking trips. He authored a leading textbook in the field which is now in the 5th edition and in 6 languages and authored over 174 articles in the medical literature and over 50 book chapters.
Raymond Mark Stein, MD,FRCSC,DABO,is a Canadian ophthalmologist. He practices refractive and cataract surgery. He is the medical director of the Bochner Eye Institute in Toronto,Ontario and Chief of Ophthalmology at the Scarborough General Hospital.
Mark S Humayun is a Pakistani-American ophthalmologist,engineer,scientist,inventor and academic –the only ophthalmologist elected a member of both U.S. National Academies of Medicine and Engineering. He is a university professor with joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering.
J. William Harbour,M.D.,is an American ophthalmologist,ocular oncologist and cancer researcher. He currently serves as the vice chairman for translational research and director of ocular oncology at the Bascom Palmer Eye Institute and the associate director for basic research at the Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine. His clinical practice focuses on intraocular tumors,including uveal (ocular) melanoma,retinoblastoma,lymphoma and other neoplasms. His field of research includes the genetics and genomics of cancer,with a focus on prognostic biomarkers,mechanisms of metastasis,and molecular targeted therapies. He has given over 300 invited scientific lectures,and published over 150 peer-reviewed scientific articles and book chapters. Dr. Harbour founded the Ocular Oncology Service at the Washington University School of Medicine in St. Louis,where he was the Paul A. Cibis Distinguished Professor of Ophthalmology &Visual Sciences.
Robert Machemer was a German-American ophthalmologist,ophthalmic surgeon,and inventor. He is sometimes called the "father of modern retinal surgery."
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital and an Honorary Consultant Ophthalmologist at the Great Ormond Street Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator,or lead researcher,for the speciality of Ophthalmology. In addition,he is a member of the research committee of Euretina:the European Society of Retina specialists,Fellow of Merton College,in Oxford and a Fellow of the Higher Education Academy.
Clare Gilbert is a professor and researcher who focuses on blindness in children based at the London School of Hygiene and Tropical Medicine.
Atul Kumar is an Indian ophthalmologist who is currently the Chief &Professor of Ophthalmology at Dr. Rajendra Prasad Centre for Ophthalmic Sciences (RPC-AIIMS),the national apex ophthalmic centre at All India Institute of Medical Sciences,Delhi. He was awarded the Padma Shri award in January 2007 for his services to the medical field. He specializes in vitreoretinal surgery and also heads the Vitreo-Retinal,Uvea and ROP services at RPC-AIIMS.
James C. Tsai is a physician and scientist who serves as president of the New York Eye and Ear Infirmary of Mount Sinai. He also serves as the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and Chair of the Department of Ophthalmology at the Mount Sinai Health System.
Elizabeth P. Rakoczy is a Hungarian-born molecular ophthalmologist. She is a professor at the University of Western Australia. She started the molecular ophthalmology department at the Lions Eye Institute. In 2017,Rakoczy was awarded the Florey Medal for her human gene therapy trial to modify viruses for the treatment of wet age-related macular degeneration.
Noemi Lois is a Clinical Professor of Ophthalmology at Queen's University Belfast and an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust.